These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36799143)

  • 21. Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency.
    Ojeniyi T; Eguavoen A; Chinye-Nwoko F
    Front Public Health; 2023; 11():1199481. PubMed ID: 37808977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 vaccination intention in the first year of the pandemic: A systematic review.
    Al-Amer R; Maneze D; Everett B; Montayre J; Villarosa AR; Dwekat E; Salamonson Y
    J Clin Nurs; 2022 Jan; 31(1-2):62-86. PubMed ID: 34227179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    Joshi A; Surapaneni KM; Kaur M; Bhatt A; Nash D; El-Mohandes A
    PLoS One; 2022; 17(6):e0269299. PubMed ID: 35679313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 Vaccine Hesitancy in a Medically-Challenged Context: A Cross-Sectional Study of Drivers, Dangers and Corrective Measures for Vaccine Hesitancy and Potential Penalties for Declining Vaccination among Adults in South-Eastern Nigeria.
    Iloh GU; Chukwuonye ME
    West Afr J Med; 2022 Sep; 39(9):889-895. PubMed ID: 36116070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 Vaccine Acceptance and Uptake in Bangkok, Thailand: Cross-sectional Online Survey.
    Remmel C; Tuli G; Varrelman TJ; Han AR; Angkab P; Kosiyaporn H; Netrpukdee C; Sorndamrih S; Thamarangsi T; Brownstein JS; Astley CM
    JMIR Public Health Surveill; 2023 Apr; 9():e40186. PubMed ID: 36811852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 vaccine hesitancy among Nigerians living with non-communicable diseases: a qualitative study.
    Ojewale LY; Mukumbang FC
    BMJ Open; 2023 Feb; 13(2):e065901. PubMed ID: 36731928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach.
    Osuagwu UL; Langsi R; Ovenseri-Ogbomo G; Mashige KP; Abu EK; Envuladu EA; Goson PC; Ekpenyong BN; Oloruntoba R; Miner CA; Charwe DD; Timothy CG; Ishaya T; Amiebenomo OM; Lim D; Agho KE
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knowledge and acceptance of COVID-19 vaccine among healthcare workers in Enugu metropolis, Enugu state, Nigeria.
    Imediegwu KU; Abor JC; Onyebuchukwu CQ; Ugwu HI; Ugwu OI; Anyaehie UE; Onyia OA
    Front Public Health; 2023; 11():1084854. PubMed ID: 37427277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 Vaccine Hesitancy and Determinants of Acceptance among Healthcare Workers, Academics and Tertiary Students in Nigeria.
    Njoga EO; Mshelbwala PP; Abah KO; Awoyomi OJ; Wangdi K; Pewan SB; Oyeleye FA; Galadima HB; Alhassan SA; Okoli CE; Kwaja EZ; Onwumere-Idolor OS; Atadiose EO; Awoyomi PO; Ibrahim MA; Lawan KM; Zailani SA; Salihu MD; Rupprecht CE
    Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Community-Based Participatory Research Approach to Developing and Testing Social and Behavioural Interventions to Reduce the Spread of SARS-CoV-2: A Protocol for the '
    Molassiotis A; Xie YJ; Leung AYM; Ho GWK; Li Y; Leung PH; Wang HL; Chen CXR; Tong DWK; Siu JY; Lau JTF
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Arizona Prevention Research Center partnerships in Arizona to promote COVID-19 vaccine health equity.
    Nuño T; Sierra LA; Wilkinson-Lee A; Carvajal S; de Zapien J; Coulter K; Figueroa C; Morales M; Sepulveda R; Sepulveda R; Ingram M
    Front Public Health; 2022; 10():944887. PubMed ID: 35958854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Vaccine Acceptance and Uptake among Healthcare Workers in Trinidad and Tobago.
    Gopaul CD; Ventour D; Thomas D
    J Environ Public Health; 2022; 2022():5031202. PubMed ID: 36120151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh.
    Mahmud S; Mohsin M; Khan IA; Mian AU; Zaman MA
    PLoS One; 2021; 16(9):e0257096. PubMed ID: 34499673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccine hesitancy and acceptance: a comprehensive scoping review of global literature.
    Majid U; Ahmad M; Zain S; Akande A; Ikhlaq F
    Health Promot Int; 2022 Jun; 37(3):. PubMed ID: 35788306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives on the COVID-19 vaccine uptake: a qualitative study of community members and health workers in Zambia.
    Sialubanje C; Mukumbuta N; Ng'andu M; Sumani EM; Nkonkomalimba M; Lyatumba DE; Mwale A; Mpiana F; Zulu JM; Mweempwa B; Endres D; Mbolela M; Namumba M; Peters WC
    BMJ Open; 2022 Nov; 12(11):e058028. PubMed ID: 36418116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability rate and barriers to COVID-19 vaccination among healthcare workers in Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Amaku-Awka, Nigeria.
    Joe-Ikechebelu NN; Umeh UM; Eleje GU; Igbodike EP; Ogbuefi EO; Akanwa AO; Echendu ST; Ngene WO; Okpala AN; Okolo OC; Okechukwu CE; Akabuike JC; Agu HO; Okpala VO; Nwazor OC; Nnedum AOU; Esimone CC; Agwaniru HN; Ezeabasili EI; Joe-Ikechebelu BB
    Ther Adv Infect Dis; 2023; 10():20499361231174776. PubMed ID: 37954403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya.
    Limaye RJ; Paul A; Gur-Arie R; Zavala E; Lee C; Fesshaye B; Singh P; Njagi W; Odila P; Munyao P; Njogu R; Mutwiwa S; Noguchi L; Morgan C; Karron R
    Vaccine; 2022 Nov; 40(50):7305-7311. PubMed ID: 36336529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 vaccine hesitancy: a systematic review of barriers to the uptake of COVID-19 vaccine among adults in Nigeria.
    Babatope T; Ilyenkova V; Marais D
    Bull Natl Res Cent; 2023; 47(1):45. PubMed ID: 36970323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community centred co-design methodology for designing and implementing socio-behavioural interventions to counter COVID-19 related misinformation among marginalized population living in the squatter settlements of Karachi, Pakistan: a methodology paper.
    Qasim R; Farooqui WA; Rahman A; Haroon R; Saleem M; Rafique M; Noor F; Ghani A; Yaqoob M; Yadav UN; Yousafzai MT
    BMC Proc; 2023 Jul; 17(Suppl 7):15. PubMed ID: 37438805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing barriers to access and equity for COVID-19 vaccination in the US.
    Kuehn M; LaMori J; DeMartino JK; Mesa-Frias M; Doran J; Korrapati L; Bhojwani R; Lefebvre P; Kirson N
    BMC Public Health; 2022 Dec; 22(1):2263. PubMed ID: 36463172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.